Idexx Laboratories | IDXX - Operating Profit

Stock Price
574.95
Daily Change
9.02 1.59%
Monthly
3.21%
Yearly
32.48%
Q2 Forecast
553.82

Idexx Laboratories reported $315.6M in Operating Profit for its fiscal quarter ending in December of 2025.





Operating Profit Change Date
Abbott USD 1.85B 399M Mar/2026
Accuray USD 4.71M 6.86M Dec/2024
Align Technology USD 224.71M 40.06M Dec/2025
AngioDynamics USD -2.51M 5.41M Sep/2025
Dentsply International USD 538M 26M Dec/2025
Dexcom USD 323M 80.5M Dec/2025
Edwards Lifesciences USD 514.7M 144.4M Mar/2026
Fujifilm JPY 89.96B 6.77B Dec/2025
Globus Medical USD 181.31M 298.83M Dec/2025
Henry Schein USD 186M 12M Dec/2025
Idexx Laboratories USD 315.6M 39.24M Dec/2025
Inogen USD -7.79M 728K Sep/2024
Insulet USD 146.3M 28.6M Dec/2025
Integra LifeSciences USD 66M 54.24M Dec/2025
Intuitive Surgical USD 859.7M 5.6M Mar/2026
Masimo USD 83.9M 300K Dec/2025
Neogen USD -3.3M 2.08M Dec/2025
Orthofix International USD 6.12M 1.91M Dec/2025
Phibro Animal Health USD 54.99M 2.36M Dec/2025
ResMed USD 497.6M 35.25M Dec/2025
Roche Holding CHF 9.56B 3.8B Dec/2025
Steris USD 278M 7.1M Dec/2025
Tandem Diabetes Care USD 8.29M 31.16M Dec/2025
Teleflex USD 36.34M 445.24M Dec/2025
Thermo Fisher Scientific USD 1.91B 389M Mar/2026
Zoetis USD 835M 101M Dec/2025